The separate ministerial declaration on the TRIPs Agreement and public health (WT/MIN(01)/DEC/2) adopted at Doha stipulates conditions under which Governments can, in effect, curtail property rights in pharmaceuticals and grant compulsory licences to domestic generic drug producers in the event of public-health crises, including human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and other epidemics.
Les engagements des agents d’exécution du système des Nations Unies ont augmenté de près de 30 %.